General Dynamics Corp
Change company Symbol lookup
Select an option...
GD General Dynamics Corp
MRNA Moderna Inc
TCOM Trip.com Group Ltd
XCOMQ Xtera Communications Inc
IBM International Business Machines Corp
MQ Marqeta Inc
K Kellogg Co
VTI Vanguard Total Stock Market Index Fund ETF Shares
EKSO Ekso Bionics Holdings Inc
ASTC Astrotech Corp
Go

Industrials : Aerospace & Defense | Large Cap Value
Company profile

General Dynamics Corporation is a global aerospace and defense company. The Company offers a portfolio of products and services in business aviation; ship construction and repair; land combat vehicles, weapons systems and munitions; and technology products and services. It operates Its operating segments include Aerospace, Marine Systems, Combat Systems and Technologies. Its Aerospace segment produces business jets and the standard bearer in aircraft repair, support and completion services. Its Marine Systems segment designs and builds nuclear-powered submarines and offers in surface combatants and auxiliary ship design and construction for the United States Navy. Its Combat Systems segment manufactures land combat solutions, including wheeled and tracked combat vehicles, weapons systems and munitions. Its Technologies segment provides a spectrum of services, technologies and products to market that seeks solutions combining electronic hardware with specialized software.

Closing Price
$213.10
Day's Change
1.73 (0.82%)
Bid
--
Ask
--
B/A Size
--
Day's High
213.62
Day's Low
209.52
Volume
(Above Average)
Volume:
1,110,957

10-day average volume:
974,277
1,110,957

Regeneron Pharmaceuticals Inc. Stock Outperforms Market On Strong Trading Day

5:19 pm ET November 8, 2021 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. (REGN) rose 1.84% to $622.78 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.09% to 4,701.70 and the Dow Jones Industrial Average rising 0.29% to 36,432.22. The stock's rise snapped a two-day losing streak. Regeneron Pharmaceuticals Inc. closed $63.84 below its 52-week high ($686.62), which the company achieved on September 3rd.

The stock outperformed some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.34% to $162.87, Novartis AG ADR (NOVN.EB) fell 0.51% to $83.22, and Amgen Inc. (AMGN) fell 1.12% to $211.37. Trading volume (639,291) remained 153,250 below its 50-day average volume of 792,541.

Data source: Dow Jones Market Data, FactSet. Data compiled November 8, 2021.

-MarketWatch Automation

	

(END) Dow Jones Newswires

November 08, 2021 17:19 ET (22:19 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.